Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideGILDGilead Sciences
FinDog View：Neutral
| Metric | DXCM | GILD |
|---|
| Close | 82.29 | 170.68 |
| Market Cap | $31.3B | $213B |
| 1M | −4.64% | +14.51% |
| P/E (TTM) | 30.2 | — |
| Forward P/E | 29.8 | 22.0 |
| P/E 5-Yr Percentile | 5 | — |
| P/S | 6.1 | 7.0 |
| P/B | 11.5 | 17.9 |
| Dividend Yield | — | 3.98% |
| Latest Quarter Revenue | $1.3B | $8.3B |
| Revenue YoY | +11.2% | +6.8% |
| Gross Margin | 64.3% | 81.1% |
| Latest Quarter EPS | 0.72 | 1.94 |
| Avg Post-Earnings Move | ±9.4% | ±3.8% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.28% | 2.57% |
| 90-Day Net Insider Buying | −$4.9M | −$15.9M |
DXCM · Revenue, Last 8 Quarters ($B)
GILD · Revenue, Last 8 Quarters ($B)
